BMRN Earnings Biomarin Pharmaceutical Inc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.54 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | 1.80 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | 2.04 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | 2.19 | 2025-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.95 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | 2.21 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | 1.56 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.01 | 2025-08-05 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.46 | 2025-05-02 | 10-Q |
| FY 2025 | 2023-12-31 | 0.87 | 2026-02-26 | 10-K |
| Q3 2024 | 2023-09-30 | 0.77 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.56 | 2024-08-05 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.27 | 2024-04-26 | 10-Q |
| FY 2024 | 2022-12-31 | 0.75 | 2025-02-24 | 10-K |
| Q3 2023 | 2022-09-30 | 0.75 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.79 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.63 | 2023-04-28 | 10-Q |
| FY 2023 | 2021-12-31 | -0.35 | 2024-02-26 | 10-K |
| Q3 2022 | 2021-09-30 | -0.03 | 2022-10-28 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.16 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.